Cargando…
370. The comparison of adverse events in combination with double beta-lactam antimicrobials: Ampicillin plus Ceftriaxone and Ampicillin/Cloxacillin with bloodstream infections
BACKGROUND: Double beta-lactams are used to treat infective endocarditis, but the incidence rate of adverse events is unclear. We aimed to compare the incidence rates of adverse events of ampicillin(ABPC) versus ABPC plus ceftriaxone(CTRX) and ABPC/MPIPC(cloxacillin). METHODS: We retrospectively inc...
Autores principales: | Ishikawa, Kazuhiro, Kobayashi, Daiki, Mori, Nobuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676930/ http://dx.doi.org/10.1093/ofid/ofad500.440 |
Ejemplares similares
-
“An antibiotic turned contraceptive”: The tale of ampicillin‐cloxacillin
por: Iheanacho, Chinonyerem O.
Publicado: (2022) -
Significant Pharmacokinetic Interactions Between Quinine and Ampicillin–Cloxacillin Combination
por: Falade, Olubunmi B., et al.
Publicado: (2016) -
Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials
por: Mirna, Moritz, et al.
Publicado: (2021) -
Ampicillin Plus Ceftriaxone Combined Therapy for Enterococcus faecalis Infective Endocarditis in OPAT
por: Herrera-Hidalgo, Laura, et al.
Publicado: (2021) -
Penicillin plus Ceftriaxone versus Ampicillin plus Ceftriaxone Synergistic Potential against Clinical Enterococcus faecalis Blood Isolates
por: Cusumano, Jaclyn A., et al.
Publicado: (2022)